CLSN RSI Chart
Last 7 days
2.2%
Last 30 days
23.7%
Last 90 days
171.2%
Trailing 12 Months
-38.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 500.0K | 500.0K | 500.0K | 500.0K |
2021 | 500.0K | 500.0K | 500.0K | 500.0K |
2020 | 512.1K | 492.5K | 443.1K | 500.0K |
2019 | 2.1M | 2.1M | 2.2M | 2.1M |
2018 | 649.7K | 649.7K | 631.3K | 456.5K |
2017 | 500.0K | 500.0K | 500.0K | 649.7K |
2016 | 500.0K | 500.0K | 500.0K | 500.0K |
2015 | 500.0K | 500.0K | 500.0K | 500.0K |
2014 | 500.0K | 500.0K | 500.0K | 500.0K |
2013 | 125.0K | 250.0K | 375.0K | 500.0K |
2011 | 0 | 0 | 0 | 2.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jul 18, 2022 | le goff corinne | acquired | - | - | 53,000 | president and ceo |
Apr 12, 2022 | tardugno michael h | bought | 14,129 | 3.5323 | 4,000 | chairman, president and ceo |
Apr 08, 2022 | fritz frederick j. | bought | 20,250 | 4.05 | 5,000 | - |
Mar 02, 2022 | fritz frederick j. | bought | 9,372 | 4.686 | 2,000 | - |
Dec 14, 2021 | kardaras constantine john | acquired | - | - | 10,000 | chief accounting officer |
Oct 07, 2021 | fritz frederick j. | bought | 17,600 | 0.88 | 20,000 | - |
May 17, 2021 | braun donald p | bought | 5,350 | 1.07 | 5,000 | - |
Feb 28, 2020 | martinez alberto r jr | bought | 4,500 | 0.9 | 5,000 | - |
Feb 25, 2020 | church jeffrey wayne | acquired | 54,520 | 1.16 | 47,000 | cfo |
Feb 25, 2020 | tumminello timothy j | acquired | 16,820 | 1.16 | 14,500 | controller |
Which funds bought or sold CLSN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Colony Group, LLC | new | - | 46,000 | 46,000 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | 13,731 | 23,457 | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | 1,566 | 2,675 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -93.00 | - | -% |
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 216 | 216 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -47.47 | 1,501 | 7,121 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -9,412 | - | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -50.00 | - | - | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -20,147 | - | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 14.87 | 111,000 | 174,000 | -% |
Unveiling Celsion Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Celsion Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -100.0% | - | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | 68,050 | 174,439 | 144,602 | 1,754,885 | 99,932 | 106,565 | 125,000 | 125,000 |
Operating Expenses | -15.4% | 5,967,627 | 7,051,751 | 6,299,566 | 6,103,271 | 5,966,977 | 5,615,868 | 5,186,576 | 5,196,402 | 5,508,344 | 4,918,840 | 4,284,600 | 4,891,997 | 4,890,995 | 4,872,666 | 5,512,526 | 5,694,758 | 4,985,523 | 4,875,367 | 4,147,220 | 8,136,353 | - |
S&GA Expenses | -40.4% | 2,414,833 | 4,048,480 | 3,890,886 | 2,876,976 | 2,871,557 | 2,629,632 | 2,718,510 | 2,602,990 | 2,936,771 | 2,108,647 | 1,792,904 | 1,901,136 | 1,838,906 | 1,807,329 | 1,838,287 | 2,136,684 | 2,217,864 | 2,531,781 | 1,959,903 | 3,542,809 | 1,665,028 |
R&D Expenses | 18.3% | 3,552,794 | 3,003,271 | 2,408,680 | 3,226,295 | 3,095,420 | 2,986,236 | 2,468,066 | 2,593,412 | 2,571,573 | 2,810,213 | 2,491,696 | 2,990,861 | 3,052,049 | 3,065,337 | 3,674,239 | 3,558,074 | 2,767,659 | 2,343,586 | 2,187,317 | 4,593,544 | - |
EBITDA Margin | 37.2% | -40.75 | -64.91 | -34.63 | -34.45 | -33.65 | -41.80 | -43.15 | -42.87 | -42.83 | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -100.0% | - | 367,513 | 127,025 | 105,024 | 4,211,856 | 114,171 | 95,520 | 221,227 | 120,313 | 606,425 | 198,739 | 243,875 | 243,299 | 246,145 | 252,144 | 255,182 | 253,289 | 253,808 | 248,270 | - | - |
EBT Margin | 44.5% | -41.59 | -74.93 | -44.31 | -44.31 | -44.31 | -44.31 | -46.66 | -46.66 | -46.66 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 63.1% | -4,888,133 | -13,232,675 | -6,148,290 | -6,042,937 | -10,474,332 | -4,221,306 | -5,410,544 | -5,448,397 | -5,689,003 | -3,012,152 | -8,071,596 | -5,342,935 | -5,056,878 | -3,102,759 | -5,476,807 | -5,904,515 | -2,367,452 | 5,480,578 | -4,656,386 | -8,230,556 | - |
Net Income Margin | 45.6% | -39.03 | -71.80 | -53.77 | -52.30 | -51.11 | -41.54 | -39.12 | -44.44 | -44.23 | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 25.8% | -3,750,117 | -5,052,467 | -4,697,100 | -5,582,718 | -8,032,410 | -5,113,734 | -3,845,085 | -2,712,938 | -4,863,459 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -34.6% | 14.00 | 22.00 | 25.00 | 29.00 | 42.00 | 44.00 | 61.00 | 65.00 | 64.00 | 74.00 | 79.00 | 83.00 | 73.00 | 38.00 | 37.00 | 47.00 | 39.00 | 38.00 | 41.00 | 44.00 | 45.00 |
Current Assets | -33.7% | 12.00 | 18.00 | 22.00 | 27.00 | 36.00 | 37.00 | 40.00 | 45.00 | 44.00 | 52.00 | 57.00 | 60.00 | 56.00 | 19.00 | 20.00 | 27.00 | 19.00 | 16.00 | 20.00 | 23.00 | 25.00 |
Cash Equivalents | -59.8% | 2.00 | 6.00 | 13.00 | 7.00 | 10.00 | 11.00 | 27.00 | 27.00 | 28.00 | 20.00 | 26.00 | 26.00 | 38.00 | 17.00 | 18.00 | 23.00 | 6.00 | 7.00 | 9.00 | 6.00 | 4.00 |
Net PPE | -7.8% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | -31.7% | 6.00 | 9.00 | 7.00 | 7.00 | 15.00 | 15.00 | 19.00 | 18.00 | 18.00 | 18.00 | 20.00 | 19.00 | 18.00 | 19.00 | 19.00 | 23.00 | 23.00 | 24.00 | 25.00 | 25.00 | 24.00 |
Current Liabilities | -34.8% | 5.00 | 7.00 | 5.00 | 6.00 | 10.00 | 10.00 | 8.00 | 7.00 | 7.00 | 7.00 | 6.00 | 5.00 | 7.00 | 7.00 | 5.00 | 9.00 | 7.00 | 8.00 | 8.00 | 7.00 | 6.00 |
Shareholder's Equity | -36.5% | 8.00 | 13.00 | 18.00 | 22.00 | 27.00 | 29.00 | 41.00 | 47.00 | 46.00 | 56.00 | 59.00 | 64.00 | 55.00 | 19.00 | 19.00 | 24.00 | 16.00 | 15.00 | 15.00 | 19.00 | 21.00 |
Retained Earnings | -1.3% | -393 | -388 | -383 | -379 | -374 | -368 | -355 | -349 | -343 | -332 | -329 | -323 | -317 | -312 | -308 | -300 | -295 | -290 | -287 | -281 | -276 |
Additional Paid-In Capital | 0.0% | 401 | 402 | 401 | 401 | 401 | 398 | 397 | 396 | 390 | 389 | 387 | 386 | 372 | 331 | 327 | 325 | 312 | 305 | 303 | 301 | 297 |
Accumulated Depreciation | -100.0% | - | 2.00 | - | - | - | 3.00 | - | - | - | - | - | - | - | - | 3.00 | - | - | 3.00 | 3.00 | 3.00 | 3.00 |
Shares Outstanding | 0% | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 2.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 12.00 | - | - | - | 13.00 | - | - | - | 110 | - | - | - | 122 | - | - | - | 38.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -57.3% | -5,900 | -3,750 | -4,472 | -6,691 | -4,085 | -5,007 | -4,640 | -5,472 | -7,976 | -5,088 | -3,786 | -2,612 | -4,736 | -3,731 | -3,963 | -2,948 | -4,975 | -5,616 | -4,480 | -4,626 | -5,535 |
Share Based Compensation | -123.0% | -30.68 | 133 | 97.00 | 190 | 339 | 710 | 476 | 492 | 995 | 686 | 701 | 794 | 1,579 | 403 | 417 | 579 | 452 | 524 | 454 | 617 | 691 |
Cashflow From Investing | 172.1% | 2,382 | -3,303 | 10,667 | 3,124 | 519 | -10,885 | 4,900 | -2,486 | 16,752 | -974 | 3,006 | -17,029 | -15,124 | -5.17 | 2,782 | 7,096 | -1,948 | 2,300 | 5,278 | 4,355 | -5,996 |
Cashflow From Financing | -100.0% | - | 30.00 | 78.00 | -6,221 | 2,474 | 447 | -64.02 | - | - | 1* | -8.32 | 14,320 | 40,457 | 2,561 | -3,132 | 12,760 | 5,795 | 1,669 | 1,711 | 2,709 | 1,755 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 3,293,861 | $ 2,619,805 |
General and administrative | 1,717,585 | 3,064,645 |
Total operating expenses | 5,011,446 | 5,684,450 |
Loss from operations | (5,011,446) | (5,684,450) |
Other income (expense): | ||
Investment income, net | 81,921 | 253,070 |
Interest expense on loan facility | (159,985) | |
Total other income (expense), net | 81,921 | 93,085 |
Net loss | $ (4,929,525) | $ (5,591,365) |
Weighted average shares outstanding - Basic | 9,399,831 | 8,281,483 |
Weighted average shares outstanding - Diluted | 9,399,831 | 8,281,483 |
Net loss per common share | ||
Net loss per common share - Basic | $ (0.52) | $ (0.68) |
Net loss per common share - Diluted | $ (0.52) | $ (0.68) |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,346,978 | $ 5,838,566 |
Investment in debt securities - available for sale, at fair value | 7,461,875 | 9,857,087 |
Advances and deposits on clinical programs and other current assets | 2,285,490 | 2,545,051 |
Total current assets | 12,094,343 | 18,240,704 |
Property and equipment (at cost, less accumulated depreciation and amortization) | 693,360 | 751,906 |
Other assets: | ||
Deferred income tax asset | 1,280,385 | |
Operating lease right-of-use assets, net | 1,487,065 | 1,595,074 |
Deposits and other assets | 50,000 | 50,000 |
Total other assets | 1,537,065 | 2,925,459 |
Total assets | 14,324,768 | 21,918,069 |
Current liabilities: | ||
Accounts payable – trade | 2,357,776 | 3,515,192 |
Other accrued liabilities | 1,958,575 | 3,390,521 |
Operating lease liability - current portion | 500,625 | 485,421 |
Total current liabilities | 4,816,976 | 7,391,134 |
Operating lease liability - non-current portion | 1,008,049 | 1,139,293 |
Total liabilities | 5,825,025 | 8,530,427 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at March 31, 2024 and December 31, 2023) | ||
Common stock - $0.01 par value (112,500,000 shares authorized; 9,400,911 and 9,399,811 shares issued at March 31, 2024 and December 31, 2023, respectively; and 9,400,889 and 9,399,789 shares outstanding at March 31, 2024 and December 31, 2023, respectively) | 94,009 | 93,998 |
Additional paid-in capital | 401,470,148 | 401,500,838 |
Accumulated other comprehensive loss | 133,101 | 60,796 |
Accumulated deficit | (393,112,327) | (388,182,802) |
Total stockholders’ equity before treasury stock | 8,584,931 | 13,472,830 |
Treasury stock, at cost (22 shares at March 31, 2024 and December 31, 2023) | (85,188) | (85,188) |
Total stockholders’ equity | 8,499,743 | 13,387,642 |
Total liabilities and stockholders’ equity | $ 14,324,768 | $ 21,918,069 |